APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level.

Yi-Hao YenFang-Ying KuoKwong-Ming KeeKuo-Chin ChangMing-Chao TsaiTsung-Hui HuSheng-Nan LuJing-Houng WangChao-Hung HungChien-Hung Chen

Published in: PloS one (2018)

We provide optimal cutoff values of both APRI and FIB-4 to predict cirrhosis stratified by AST levels, which should be more feasible compared with the single cutoff values proposed in previous studies.

Keyphrases

liver fibrosis
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
patient reported outcomes
patient reported